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were analyzed by means of descriptive statistics and linear regression mode-
ling. Results: Most diabetes patients are reporting pain, only 29% of the patients 
reports no pain or discomfort. 48% of the patients report mobility problems, 36% 
reports problems with usual activities, 34% report problems with anxiety or depres-
sion. Only 10% of diabetes patients report problems with self-care. From a regression 
modeling point of view, with EQ-5D dimensions used to predict VAS scores, pain/
discomfort scores have a standardized β –value of -0,44. For the other dimensions 
the following β –values were found anxiety/depression (-0,3), mobility (-0,22), self-
care (-0,21), and usual activities (-0,09). ConClusions: From the five dimensions 
included in the EQ-5D-5L pain/discomfort has the largest negative influence on 
the HRQoL of diabetes patients, problems with usual activities and self-care have 
least impact. Although a lot of research has already been conducted in the field of 
diabetes patient pain/discomfort management further investigation is warranted.
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HealTH STaTe UTiliTieS aSSociaTed WiTH aTTribUTeS of TreaTmenTS 
for HepaTiTiS c
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Feeny DH5
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objeCtives: Current treatments for chronic hepatitis C (CHC) are frequently asso-
ciated with complex regimens and serious adverse events. Little is known about 
the impact of these treatment attributes on health state utilities. The purpose of 
this study was to estimate the utility or disutility (i.e., utility decrease) associated 
with treatment administration and adverse events of CHC treatments. Methods: 
Health states were drafted based on literature review and expert clinician inter-
views. General population participants in the UK (London, Edinburgh) valued the 
health states in time trade-off (TTO) interviews with both 10-year and 1-year time 
horizons. The 14 health states described hepatitis C with variations in treatment 
attributes: number of tablets per day, weekly injection, fatty food requirement, and 
six adverse events. Results: A total of 182 participants completed interviews (50% 
female; mean age = 39.3y). In treatment regimens without injections, greater num-
bers of tablets were associated with slightly lower utility (1 tablet = 0.80; 2 tablets = 
0.80; 3 tablets = 0.80; 7 tablets = 0.79). Utilities for health states describing regimens 
with oral and injectable medication were 0.77 (7 tablets), 0.75 (12 tablets), and 0.71 
(18 tablets). Addition of a weekly injection to a 7-tablet regimen had a disutility 
of -0.02. The requirement to take tablets with fatty food had a disutility of -0.04. 
Adverse events were associated with substantial disutilities: mild anemia, -0.12; 
severe anemia, -0.32; flu-like symptoms, -0.21; mild rash, -0.13; severe rash, -0.48; 
depression, -0.47. These utilities are from the 10-year TTO; one-year scores were very 
similar. ConClusions: Adverse events and greater treatment regimen complexity 
were associated with utility reductions, suggesting a perceived decrease in quality 
of life beyond the impact of hepatitis C itself. The resulting utilities may be used in 
models estimating and comparing the value of treatments for hepatitis C.
UT3
aSSeSSing facTorS aSSociaTed WiTH Self-reporTed HealTH STaTUS in 
THe UniTed STaTeS USing a STrUcTUral eqUaTion model
Zhao Y, Gu NY
University of New Mexico, Albuquerque, NM, USA
objeCtives: To assess the relationship between self-reported health status and 
lifestyle, access to health care and individual characteristics using a U.S. representa-
tive sample. Methods: A cross-sectional study using the 2011 US Behavioral Risk 
Factor Surveillance System (BRFSS) Survey database was performed. A structural 
equation model (SEM) was applied to investigate individual characteristics factors 
(age, body mass index (BMI), income and education levels), lifestyle factors (fruit, 
vegetable and alcohol consumptions and exercise levels), and access to health care 
factors (statuses on insurance, private health care provider and barrier to health 
service due to cost) that influence various self-reported health statuses (general 
health status, physical health status and mental health status). Results: The mean 
age of the study population was about 43.5 years with 51.2% being female. The 
measures of model fitness (RMSEA< 0.05 is 0.951; GFI= 0.954) showed the internal 
structure of the model was acceptable and the observed variables would suffice in 
accounting for latent variables. The proportion of variance in each indicator was 
explained well by its respective latent variable (e.g. 58.7% of variance in general 
health, 60.4% in insurance and 59.0% in income were explained). All independent 
latent variables (access to health care, individual characteristics and lifestyle) were 
significantly associated with health status. Individual characteristics factors have 
the largest effect (β = 0.719) on health status, followed by lifestyle factors (β = 0.141) 
and access to health care factors (β = 0.136). ConClusions: Our findings show that 
improved access to health care and lifestyle were associated with increased self-
reported health status. In particular, older individuals with high BMI index and low 
socioeconomic status were more likely to report worse health status.
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compUTerized adapTive TeST ScoreS for aSSeSSing paTienT oUTcomeS
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objeCtives: There is great interest in using computerized adaptive tests (CAT) to 
assess health outcomes. CATs are based on Item Response Theory (IRT) and yield 
a numeric estimate, but it is difficult to interpret the health status and clinical 
meaning from these scores. Item maps generated from IRT analyses and book-
marking procedures facilitate development of levels, and provide a meaningful 
context for CAT scores. We aim to develop and validate the levels for Spinal Cord 
Injury Functional Index (SCI-FI) used as a functional outcome measure for persons 
with SCI. The specific objectives are: (i) Develop levels for five SCI-FI domains: 
basic mobility, self-care, fine motor, wheelchair and ambulation; (ii) Determine 
but not significantly increased risk of hemorrhagic stroke (HR: 1.43; 95% CI: 0.80-
2.56). ConClusions: Warfarin discontinuation is associated with increased risk of 
ischemic stroke and TIA in NVAF patinets. Further study is warranted to examine 
long-term clinical and economic outcomes of warfarin discontinuation.
ri3
diSpariTy in HigH riSk medicaTion USe beTWeen dUal and non-
dUal eligible medicare advanTage beneficiarieS: a decompoSiTion 
analySiS
Pulungan Z, Parente A, Mehta S, Jones B, Teigland C
Inovalon Inc., Bowie, MD, USA
objeCtives: The CMS Five Star Rating system for Medicare Advantage (MA) informs 
beneficiaries about plan performance and determines Quality Bonus Payments. High 
Risk Medication (HRM) use is a triple weighted measure defined as the percent of 
beneficiaries aged 65+ who received two or more fills for a drug with high risk of 
serious side effects in the elderly. This analysis evaluates differences in HRM use 
between dual eligible (DE) and non-DE members and examines the contribution of 
socio-demographic and clinical characteristics to observed disparities. Methods: 
The study used a nationally representative administrative claims database of 1.5 
million MA members in 2011-2012 (measured in member years): 232,273 DE (female: 
66.3%; average age 75.4) and 1,251,145 non-DE (female 57.4%; average age 75.2). 
The Linear Probability Model (LPM) and Blinder-Oaxaca decomposition techniques 
with Neumark weighting formula were performed. Results: HRM rate was 32.2% 
higher in DEs (16.8% vs. 12.7%). The decomposition analysis found member char-
acteristics accounted for only 48% of the performance gap (“explained gap”); 52% 
was attributed to differential effects of member characteristics on HRM use (“unex-
plained gap”). The Charlson Severity Score indicates more complex comorbidities 
in DEs (2.34 vs. 1.77) and explained 70.6% of the difference in HRM use; disability as 
original reason for entitlement explained 23.3%. Members of a Preferred Provider 
Organization (PPO) and older members were less likely to use HRMs, while females 
and low income members were associated with higher use. ConClusions: This 
study provides information about the contribution of socio-demographic and clini-
cal characteristics to higher use of HRMs in DEs, and can support targeted interven-
tions to reduce the performance gap. The analysis further demonstrates that more 
than half the disparity is not explained by the member characteristics evaluated 
and points to the need for further research to understand the factors behind the 
unexplained DE gap.
ri4
riSk facTorS aSSociaTed WiTH meTHicillin-reSiSTanT 
STapHylococcUS aUreUS (mrSa) bacTeremia in THe UniTed STaTeS
Pawar AM, Willey CJ, Caffrey AR
University of Rhode Island, Kingston, RI, USA
objeCtives: MRSA bacteremia is associated with significantly greater mortal-
ity, length of stay (LOS), and hospital costs compared to methicillin-susceptible S. 
aureus (MSSA) bacteremia. With the changing epidemiology of S. aureus infections, 
we sought to identify risk factors for MRSA bacteremia. Methods: Our case-control 
study identified MRSA (cases) or MSSA (controls) bacteremia hospitalizations, using 
diagnosis codes, from the 2009 Nationwide Inpatient Sample (n= 7,810,762). These 
were further categorized into community-associated (principal diagnoses) or hospi-
tal-associated (secondary diagnoses) infections. Significant independent predictors 
of MRSA bacteremia, as compared to MSSA bacteremia, were identified from logistic 
regression models. Differences in outcomes were assessed with χ 2 or Wilcoxon 
tests. Results: Our study included 12,907 MRSA and 9,380 with MSSA bactere-
mia hospitalizations. Lower median household income (< $38,999 versus $63,000 
or more) was significantly associated with MRSA bacteremia (odds ratio [OR]= 1.34, 
p< 0.01). African Americans (OR= 1.32, p< 0.01) were at higher risk while Asian or 
Pacific Islanders (OR= 0.80, p= 0.02) were at lower risk of developing MRSA bacte-
remia compared to Whites. The presence of certain comorbidities increased the 
risk of MRSA bacteremia as compared to MSSA (p< 0.01): paralysis (OR= 1.65), other 
neurological disorders (OR= 1.38), chronic pulmonary disease (OR= 1.27), peripheral 
vascular disease (OR= 1.27), psychosis (OR= 1.23), weight loss (OR= 1.19), and renal 
failure (OR= 1.13). Alternatively, the odds of other comorbidities were lower with 
MRSA bacteremia (p< 0.01): coagulopathy (OR= 0.85), hypertension (OR= 0.84), and 
metastatic cancer (OR= 0.77). Similar results were found in community-associated 
and nosocomial infection subgroups. MRSA was associated with significantly higher 
mortality (MRSA 63%, MSSA 37%), LOS (MRSA 16 days, MSSA 14 days), and hospital 
costs (MRSA $114,176, MSSA $104,408) (p< 0.01). ConClusions: Our study identified 
additional predictors of MRSA bacteremia among a large, nationally representative 
source population of 7 million patients. These included income, race, and comorbidi-
ties, which were either risk factors for MRSA bacteremia, as compared to MSSA, or 
protective against MRSA, indicating a greater association with MSSA.
UTiliTy meaSUremenT STUdieS
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eq-5d: WHicH dimenSion maTTerS moST among diabeTeS paTienTS
Dierick K.1, Mcbride M.2, Love T.2, Dean C.3, Pike I.3, Herterich R.4
1GfK Disease Atlas, Brussels, Belgium, 2GfK USA, New York, NY, USA, 3GfK NOP, London, UK, 
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objeCtives: EQ-5D is a frequently applied instrument to measure Health Related 
Quality of Life (HRQoL) among patients. The HRQoL is measured based on a 
5-item questionnaire covering: mobility, self-care, usual activities, pain/discom-
fort, and anxiety/depression. The objective of our study was to identify which of 
these 5 dimensions has the biggest influence on the HRQoL scores of diabetes 
patients. Methods: A cross-sectional survey of diabetes patients (n = 1480) liv-
ing in the United States. Each patient completed a questionnaire, which included 
the EQ-5D-5L instrument and accompanying VAS. Scores provided by the patients 
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minimum data sets. ConClusions: The Saudi National e-health Strategy will 
leverage the ICD-10 implementation.
pHp3
iS fda’S breakTHroUgH THerapy deSignaTion a game-cHanging Trend 
for paTienTS and payerS?
Aggarwal S., Topaloglu H.
Novel Health Strategies, Bethesda, MD, USA
objeCtives: In 2012 United States Food and Drug Administration (FDA) created 
a new expedited pathway of ‘Breakthrough Therapy Designation’ (BTD) to enable 
early approval of therapies, which have shown substantial activity in early trials. 
The objective of this study was to understand the impact on BTD on patients and 
payers. Methods: The data for number of granted BTDs was obtained from FDA.
gov. The data for publically disclosed BTDs was obtained from sponsor’s press 
releases. For all products the information for their mechanism of action, type of 
molecule, trial design, clinical efficacy and safety, and pricing and time to approval 
(for approved products) were obtained from peer-reviewed publications, confer-
ence abstracts, FDA and sponsor websites. Results: Since the establishment of the 
BTD pathway, 37 products have been granted breakthrough therapy designations 
(2012-2013), of which, 28 have been publically disclosed by the manufacturers and 
3 have been approved by the FDA. In terms of indications, 12 (43%) are for cancer, 
5 (18%) are for genetic diseases and 4 (14%) are for Hepatitis C Genotype 1. The 
three approved drugs with BTD are Gazyva, Imbruvica and Sovaldi. The median 
time to approval for these three drug was ~5 years, significantly shorter than the 
2012 median time to approval for priority review applications (6 years). However, 
the price premium was 30-50% compared to other drugs in the same category. Two 
of the drugs with BTD did not meet primary endpoint in their pivotal trial. While 
the BTD pathway promises to reduce development time, the high price is a major 
concern for payers and patients. ConClusions: BTD is a promising pathway to 
shorten development time and provides early access, however, high price could 
pose challenges for payers and patients.
pHp4
4 yoUr kidS care: redUcing non-emergenT HoSpiTalizaTion in a 
medicaid pediaTric popUlaTion THroUgH HandS-on Training and 
parenT/caregiver edUcaTion
Grant M., Honeywell A., Dinsmore S., Keleti D., Michael K.E., Tan-Torres S., Higgins Y.L.
AmeriHealth Caritas Family of Companies, Philadelphia, PA, USA
objeCtives: As a Medicaid managed care organization (MCO), Keystone First 
experiences a high volume of pediatric members receiving care for common 
childhood illnesses at hospital emergency departments (EDs). The 4 Your Kids 
Care program educates parents/caregivers about what to do when their chil-
dren get sick, encourages members to engage their primary care physicians, 
and refers families to appropriate plan resources (e.g., 24/7 Nurse Hotline and 
Care Management). Methods: A 2.5-hour program educates parents/caregivers 
about treating common pediatric illnesses at home. The study group (SG) con-
sisted of participating parents/caregivers of 585 pediatric members (≤ 5 years old) 
in Philadelphia and Delaware counties (Pennsylvania) with at least one prior-
year non-emergent ED claim. The matched control group (CG) consisted of 1,189 
pediatric members with nonparticipating parents/caregivers in the pre-period 
and 1,153 in the post-period. The baseline period (January 1, 2010–December 31, 
2010) where non-urgent ED claims were collected was followed by the class period 
(January 1, 2011–September 30, 2011) and one-year follow-up period (October 1, 
2011–December 31, 2012). Participants completed a knowledge assessment both 
before commencement and after completion of the class. Results: While the 
average number of ED visits for non-urgent conditions decreased significantly dur-
ing the 12-month period in SG (p< 0.0001) and CG (p= 0.0097), the mean reduction 
for SG was more than three-fold greater than CG (-46.3% vs. -14.6%, respectively). 
Amounts paid for ED claims for non-urgent visits during the 12-month period for 
SG decreased by over twice the amount of CG (-37.8% vs. -17.4%). Questionnaire 
respondents displayed significant improvements in all six questions regarding 
knowledge assessment (p< 0.01). Participant evaluations of the program were 
overwhelmingly favorable. ConClusions: 4 Your Kids Care provided effective 
parent/caregiver education, improved health literacy, and significantly reduced 
non-emergent pediatric member ED utilization and costs.
pHp5
role of paTienT inpUT in THe cedac drUg reimbUrSemenT deciSion 
making proceSS
Dionne P.A., Weicker S., Remple V, Tran T.
Pfizer Canada, Kirkland, QC, Canada
bACkgRound: Since 2010, the Canadian Agency for Drugs and Technologies 
in Health (CADTH), via the Common Drug Review (CDR), have allowed patient 
groups to submit issues and outcomes important to them to inform Canadian 
Expert Drug Advisory Committee (CEDAC) recommendations on drug reimburse-
ment. objeCtives: The objectives were to determine if the inclusion of patient 
input into the CDR process resulted in any change in the CEDAC positive fund-
ing recommendation (PFR) rate and to assess potential factors associated with 
a PFR. Methods: CEDAC recommendations (May 2004 to December 2013) were 
obtained from the CADTH website. “Efficacy” was defined as occurring when an 
outcome(s) identified as important to patients achieved statistically significant 
improvement versus placebo or similar/improved results versus active comparators. 
Trends in PFR were characterized using descriptive statistics and factors associated 
with a PFR were assessed using logistic regressions Results: The PFR rate for the 
153 recommendations published prior to the patient input process was 54% which 
was similar to the PFR rate (56%) for the 89 recommendations published after the 
process was established. A PFR rate of 58% was observed in the 65 submissions that 
included patient input and 50% in the 24 submissions without. Submissions that 
showed efficacy in outcomes important to patients had a similar PFR rate (60%) than 
if outcome scores for the levels are significantly different; (iii) Ascertain whether 
levels distinguish people of varying clinical profile (injury level and complete-
ness). Methods: A three-phase analytic approach involving quantitative and 
qualitative methodology was deployed: (a) SCI-FI items were ordered along a 
continuum of difficulty using IRT, and empirical item maps were generated from 
calibration study data (N= 855); (b) Delphi approach was employed with expert 
panel (n= 6) reviewing item maps and arriving at consensus for cut-off scores for 
level development; and (c) Developed levels were described and refined for mean-
ingful outcome interpretation. One-way ANOVAs were performed (levels as factor, 
SCI-FI CAT scores as dependent variable). Chi square analyses were performed to 
compare actual to expected number of persons at each level for the varied clini-
cal profiles, paraplegia-complete, paraplegia-incomplete, tetraplegia-complete 
and tetraplegia-incomplete. Results: Five levels representing varying range of 
functional outcomes were identified for all the SCI-FI domains except one hav-
ing four levels. ANOVA (pair-wise comparisons) results revealed significant score 
differences across levels. Chi-square tests were significant in the hypothesized 
direction. ConClusions: Developed levels define patient functional outcomes 
that provide meaningful interpretation of CAT scores for use in research and 
patient monitoring.
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effecT of involvemenT on informaTion proceSSing from over-THe-
coUnTer drUg facTS panel
Bhansali A.H., Sansgiry S.S.
University of Houston, Houston, TX, USA
objeCtives: The study objective was to assess the effect of involvement on infor-
mation processing from over-the-counter (OTC) Drug Facts panel. Methods: In 
this experimental, cross-sectional study the effect of extrinsic involvement when 
processing two experimental labels was evaluated. Labels designed based on con-
cepts of chunking, congruency and information placement were compared to the 
current OTC label. Extrinsic involvement was measured using a previously vali-
dated and reliable scale along with information processing variables measured 
using the OTC-label evaluation process model. The participants were tested for 
label comprehension, ease of use, attitude towards the label, product evaluation 
and purchase intention. Data was coded and analyzed using SAS® 9.3 at an apri-
ori significance level of 0.05. MANCOVA, ANCOVA, Dunnett’s post-hoc analyses 
were done to test the study objective. Results: Of the 249 survey participants 
(81.4% response rate) majority were females (55.4%) with a mean age of 36.8 (± 
9.6) years. Most of them had a college level education (54.2%) and worked in the 
health care field (61.4%). In general, extrinsic involvement scores were high (3.81 ± 
1.03). MANCOVA indicated a statistically significant effect of involvement between 
the label types (p< 0.0001). ANCOVA and Dunnett’s post hoc revealed that the level 
of involvement for attitude towards the label was significantly higher for Label 
A with warnings placed after the chunk (Uses, Directions, Other Information) as 
compared to Label B with warnings placed before the chunk and Label C, the current 
OTC label (p< 0.0001). ConClusions: Consumer involvement plays a significant 
role in information processing. Consumer attitude towards the label information 
is affected by their level of involvement. When the consumer is more involved he 
is more likely to understand the given information and have a favorable attitude 
towards the product.
pHp2
icd-10 implemenTaTion in SaUdi arabia: cHallengeS and 
opporTUniTieS! e-HealTH iS TranSforming medical recordS To HealTH 
informaTion managemenT!
Albishi H.A.
Ministry of Health, RIYADH, Saudi Arabia
objeCtives: ICD-10 is mandated by the World Health Organization (WHO). It 
codes diseases, signs and symptoms, abnormal findings, complaints, social cir-
cumstances, and external causes of injury or diseases. ICD-10 coding is used for 
measuring the quality, safety and efficacy of care, tracking public health concerns, 
epidemiological studies, and, improving clinical, financial, and administrative per-
formance. Accurate and precise coding utilizing standardized methodologies on 
a national scale is both challenging and meticulous process. This paper aims to 
highlight the implementation challenges of ICD-10 coding in Saudi Arabia from 
the year (2007) to the year (2014). The main challenges and opportunities observed 
during the implenetaion process will be presented. Methods: The methodology 
of the implementation process of ICD-10 started in 2007, the first step started with 
signing an agreement between the Saudi Arabia and Australia to obtain a license 
agreement, the second step was creating a committee to oversee the implementa-
tion, and the third step was preparing an implementation guide with the following 
objectives, to increase the level of awareness to understand the ICD-10 impact, 
and enable hospitals and software vendors to adopt to the new system. Results: 
ICD-10 implantation faced some challenges, some were coders-related and some 
were organization-related. Among the most important coders challenges were the 
lack of ICD-10 training resources, poor English literacy, and significant shortage of 
coders (7%) and medical records staff (45%). The absence of a clear professional 
career path for Hospital Information Management (HIM) Specialists and Clinical 
Coders has played an important role in limiting the coding process in Saudi Arabia. 
Organization challenges included lack of ICD-10 awareness, poor technical infra-
structure, lack of interoperability with legacy and dated Hospital Information 
Systems, and the lack of a Discharge Abstract Data (DAD) System with defined 
